Become A Featured Company

Koios Launches New Products, Expands Distribution & Begins Clinical Trials in the Functional Food & Beverage Space

Ryan Allway

August 14th, 2018

Exclusive, News, Top News

The global nutraceutical market is projected to reach more than US$300 billion by 2024, according to Zion Market Research, driven by consumers taking a more active role in their health. Functional food and beverages that provide health benefits and enjoyment are one of the fastest growing segments of that market. Investors looking for exposure may want to consider small-cap companies on the verge of scaling up their operations.

Koios Beverage Corp. (CSE: KBEV) (OTC Pink: SNOVF) is a functional food and beverage company focused on cognitive enhancements. In addition to these products, the company recently announced that it’s developing a cannabis-infused beverage that could deliver the benefits of cannabinoids in the form of an enjoyable beverage. Investors may want to take a closer look at the company as it launches new products and gears up for commercialization.

New Product Launches

Koios Beverage has been working with the best food scientists in the United States on developing new formulations of its functional cognitive-enhancing beverages. After more than four years of research and development, in late July the company launched the first product to leverage the new formulation — a Pear Guava taste profile and a proprietary blend of nootropics and superfoods, including Lion’s Mane Mushroom.

“This product has taken more than four years of trial and error to ensure efficacy, and to perfect the flavor,” said CEO Chris Miller, who founded the company in part due to his own struggles with attention deficit hyperactivity disorder, or ADHD. “Combining these two elements is incredibly difficult and we are confident that with this new line,  we have delivered a product that not only tastes great, but has incredible health benefits to consumers.”

The company intends to launch several new flavors over the near-term, including Peach Mango, Blood Orange, Apricot Vanilla, and Berry Genius. In addition to these beverages, the company also offers powder products that packs three times the active ingredients of the drinks per serving. These products could be appealing to individuals that wish to mix the active ingredients into smoothies or their own drinks.

Expanding Distribution

Koios Beverage has built an impressive distribution footprint in the United States, with products appearing in Europa Sports, Muscle Foods USA, KeHE, and Amazon’s Wishing-U-Well, as well as through its own ecommerce website. But, the company’s ambitions aren’t limited to the United States — the company hopes to eventually launch its products to a global audience over the coming quarters.

In early-July, the company took a big step forward in expanding its distribution on a global scale with the launch of direct shipping to Canada. Canadian consumers had been reaching out for some time to the company, seeking to purchase its products, according to the company’s press release. That demand led to the decision to add functionality to their ecommerce website, enabling Canadians to purchase products and have them shipped directly to Canada.

“The idea of using nootropic supplements to help boost focus and mental acuity has been catching on with people around the world, not just the United States,” said Mr. Miller. “We have particularly been seeing increased demand for our products in Canada, and are happy to be able to now meet that demand with our global shipping program. Our mission is to bring the benefits of nootropic supplements to the world.”

Clinical Trials Underway

There are thousands of different companies with nootropic products designed to improve cognitive performance, but there’s one thing that distinguishes the proverbial snake oil salespeople from the experts in cognitive enhancement — clinical research.

Koios Beverage has an agreement with NeuraPerformance/Neuroptimize Brain Center to perform full clinical brain scans on its users to assess and quantify the cognitive performance impact. The go-to brain lab and physiotherapy clinic has been a top choice for elite athletes in Colorado, including the Denver Broncos, and they specialize in brain mapping, brainwave optimization, enhancing sports performance, and baseline concussion testing and treatment.

“Not only will this clinical trial differentiate our product formulation, but the data collected will pave the way to creating better technologies within our portfolio, and fulfilling our mission of creating one of the most functional organic products that support and enhance brain health and performance,” said Mr. Miller.

The company anticipates initial results from the clinical trial this month, which could become a catalyst for the stock if they’re positive.

Looking Ahead

Koios Beverage Corp. (CSE: KBEV) (OTC Pink: SNOVF) represents a compelling investment opportunity in the functional food and beverage industry. With a focus on cognitive enhancement, the company has been making solid progress in launching new product formulations, expanding its distribution, and conducted R&D that could both prove out its existing products and open the door to future innovations.

For more information, visit the company’s website at www.mentaltitan.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading